Literature DB >> 25355695

Implementing socially responsible licensing for global health: beyond neglected diseases.

Jenilee M Guebert1, Tania Bubela2.   

Abstract

Global health efforts require socially responsible licensing that permits wide-ranging access to inventions that address health challenges beyond the so-called neglected diseases. Our analysis suggests that universities that excel in global health innovation are less likely to have global-access licensing policies in place. This trend can slow access to new clinical products and diminish the ability of universities to address their public missions.
Copyright © 2014, American Association for the Advancement of Science.

Mesh:

Year:  2014        PMID: 25355695     DOI: 10.1126/scitranslmed.3009422

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  7 in total

Review 1.  Accelerating pooled licensing of medicines to enhance global production and equitable access.

Authors:  Kenneth C Shadlen
Journal:  Lancet       Date:  2022-07-08       Impact factor: 202.731

2.  Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.

Authors:  Alistair Story; Richard S Garfein; Andrew Hayward; Valiantsin Rusovich; Andrei Dadu; Viorel Soltan; Alexandru Oprunenco; Kelly Collins; Rohit Sarin; Subhi Quraishi; Mukta Sharma; Giovanni Battista Migliori; Maithili Varadarajan; Dennis Falzon
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

3.  Global health equity in United Kingdom university research: a landscape of current policies and practices.

Authors:  Dzintars Gotham; Jonathan Meldrum; Vaitehi Nageshwaran; Christopher Counts; Nina Kumari; Manuel Martin; Ben Beattie; Nathan Post
Journal:  Health Res Policy Syst       Date:  2016-10-10

4.  Global health research and education at medical faculties in Germany.

Authors:  Léonie Karduck; Anna Lisa Behnke; Alicia Baier; Dzintars Gotham; Peter Grabitz; Nora Lennartz; Lara Speer; Peter Tinnemann; Walter Bruchhausen
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

5.  Public-private knowledge transfer and access to medicines: a systematic review and qualitative study of perceptions and roles of scientists involved in HPV vaccine research.

Authors:  Rosa Jahn; Olaf Müller; Stefan Nöst; Kayvan Bozorgmehr
Journal:  Global Health       Date:  2020-03-05       Impact factor: 4.185

6.  Digital health for the End TB Strategy: developing priority products and making them work.

Authors:  Dennis Falzon; Hazim Timimi; Pascal Kurosinski; Giovanni Battista Migliori; Wayne Van Gemert; Claudia Denkinger; Chris Isaacs; Alistair Story; Richard S Garfein; Luis Gustavo do Valle Bastos; Mohammed A Yassin; Valiantsin Rusovich; Alena Skrahina; Le Van Hoi; Tobias Broger; Ibrahim Abubakar; Andrew Hayward; Bruce V Thomas; Zelalem Temesgen; Subhi Quraishi; Dalene von Delft; Ernesto Jaramillo; Karin Weyer; Mario C Raviglione
Journal:  Eur Respir J       Date:  2016-05-26       Impact factor: 16.671

7.  Charging for the use of survey instruments on population health: the case of quality-adjusted life years.

Authors:  Yot Teerawattananon; Alia Cg Luz; Anthony Culyer; Kalipso Chalkidou
Journal:  Bull World Health Organ       Date:  2019-10-28       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.